Ekimas Corp ASNB
We take great care to ensure that the data presented and summarized in this overview for EKIMAS Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ASNB
Top Purchases
Top Sells
About ASNB
EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Insider Transactions at ASNB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2025
|
Henrik Rouf Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,667
-62.54%
|
$53,334
$2.0 P/Share
|
|
Aug 08
2025
|
Gk Partners Ap S > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
23,300
-0.71%
|
$46,600
$2.0 P/Share
|
|
Jul 30
2025
|
Nordic Ap S Ac > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+3.11%
|
$100,000
$1.9 P/Share
|
|
Jul 03
2025
|
Nordic Ap S Ac > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
42,500
+1.39%
|
$42,500
$1.9 P/Share
|
|
Jul 02
2025
|
Nordic Ap S Ac > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.83%
|
$25,000
$1.9 P/Share
|
|
Jun 16
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
7,000
+0.21%
|
$28,000
$4.44 P/Share
|
|
Jun 16
2025
|
Nordic Ap S Ac > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
35,000
+1.17%
|
$140,000
$4.0 P/Share
|
|
Jun 02
2025
|
Nordic Ap S Ac > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,982
+0.07%
|
$15,856
$8.85 P/Share
|
|
May 28
2025
|
Gk Partners Ap S > 10% Shareholder |
SELL
Open market or private purchase
|
Direct |
49,953
-1.5%
|
-
|
|
May 28
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
113,095
+3.29%
|
-
|
|
May 28
2025
|
Gk Partners Ap S > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
109,750
-3.3%
|
-
|
|
May 28
2025
|
Nordic Ap S Ac > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
222,845
-3.62%
|
-
|
|
May 22
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,000
+0.18%
|
$30,000
$5.0 P/Share
|
|
May 16
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,000
+0.36%
|
$60,000
$5.0 P/Share
|
|
May 02
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.63%
|
$105,000
$5.0 P/Share
|
|
Apr 22
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.3%
|
$50,000
$5.0 P/Share
|
|
Feb 19
2025
|
Gk Partners Ap S > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
49,165
-1.48%
|
$196,660
$4.0 P/Share
|
|
Feb 18
2025
|
Nordic Ap S Ac > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,500
-0.12%
|
$7,500
$1.9 P/Share
|
|
Feb 18
2025
|
Nordic Ap S Ac > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000
+0.06%
|
$10,000
$5.0 P/Share
|
|
Feb 13
2025
|
Gk Partners Ap S > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
11,224
+0.34%
|
$89,792
$8.91 P/Share
|
Last 12 Months Summary
| Conversion of derivative security | 11.2K shares |
|---|---|
| Open market or private purchase | 387K shares |
| Open market or private sale | 278K shares |
|---|---|
| Open market or private purchase | 50K shares |
| Bona fide gift | 223K shares |